What's New
Front Page
AFTD Senior Director of Scientific Initiatives Discusses FTD and ALS at 2022 Target ALS Annual Meeting
AFTD Senior Director of Scientific Initiatives Penny Dacks, PhD, discussed the overlapping disease pathology between ALS and…
ALS Awareness Month: Understanding an ALS with FTD Diagnosis
May is ALS Awareness Month, a time to raise awareness about amyotrophic lateral sclerosis (ALS), and during…
Model Discusses FTD Advocacy in “Sports Illustrated” Article
Model and FTD caregiver Nicole Petrie discussed why she’s spreading FTD awareness in a recent Sports Illustrated…
FTD Insights Survey Data Presented at Latinos & Alzheimer’s Symposium
FTD data focused on the perspectives of Latino Americans living with and impacted by FTD was presented…
Activist Living with FTD Discusses Dementia Advocacy in Asia in “Being Patient” Interview
Emily Ong, who lives with FTD, discussed her efforts to combat the challenges of dementia advocacy in…
AFTD 2022 Education Conference Session Recordings Now Available on YouTube
Did you miss the AFTD Education Conference? Want to share a session that you found informative? Recordings…
AFTD CEO Discusses FTD and ALS at 2022 Target ALS Annual Meeting
AFTD CEO Susan L-J Dickinson, MSGC, talked about FTD and its connection to ALS during an interview…
Neurofilament Light Potentially Useful as FTD Biomarker, Study Finds
Neurofilament light (NfL), a recognized biomarker linked to neurodegeneration, has been proven to be a useful blood-based…
Persons With End-Stage Dementia May Have Difficulty in Receiving Hospice Care, “Washington Post” Reports
Hospice stays for persons with FTD or other dementias could be harder to access through Medicare if…
“Vogue” Covers AFTD’s 2022 Hope Rising Benefit
(L-R: AFTD CEO Susan L-J Dickinson, AFTD Board member Donald E. Newhouse, Hope Rising Benefit Chair David…
English 
Spanish (Mexico) 
French 
German 
Swedish 
Portuguese 
Italian 
Dutch 
Danish 
Polish 
Spanish (Spain)